| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Enlivex Therapeutics Ltd (NASDAQ: ENLV)
ENLV Technical Analysis
5
| As on 24th Nov 2025 ENLV SHARE Price closed @ 1.02 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.11 & Strong Sell for SHORT-TERM with Stoploss of 1.15 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ENLVSHARE Price
| Open | 1.59 | Change | Price | % |
| High | 1.81 | 1 Day | 0.12 | 13.33 |
| Low | 1.00 | 1 Week | 0.03 | 3.03 |
| Close | 1.02 | 1 Month | -0.08 | -7.27 |
| Volume | 207474508 | 1 Year | -0.12 | -10.53 |
| 52 Week High 1.82 | 52 Week Low 0.86 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| NVDA | 182.55 | 2.05% |
| ENLV | 1.02 | 13.33% |
| ONDS | 8.72 | 29.57% |
| OPEN | 7.69 | 13.93% |
| LMDX | 0.02 | 0.00% |
| PLUG | 1.96 | -1.01% |
| INTC | 35.79 | 3.74% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ENLV Daily Charts |
ENLV Intraday Charts |
Whats New @ Bazaartrend |
ENLV Free Analysis |
|
|
ENLV Important Levels Intraday
| RESISTANCE | 2.58 |
| RESISTANCE | 2.08 |
| RESISTANCE | 1.77 |
| RESISTANCE | 1.46 |
| SUPPORT | 0.58 |
| SUPPORT | 0.27 |
| SUPPORT | -0.04 |
| SUPPORT | -0.54 |
ENLV Forecast November 2025
| 4th UP Forecast | 1.56 |
| 3rd UP Forecast | 1.39 |
| 2nd UP Forecast | 1.28 |
| 1st UP Forecast | 1.17 |
| 1st DOWN Forecast | 0.87 |
| 2nd DOWN Forecast | 0.76 |
| 3rd DOWN Forecast | 0.65 |
| 4th DOWN Forecast | 0.48 |
ENLV Weekly Forecast
| 4th UP Forecast | 1.46 |
| 3rd UP Forecast | 1.32 |
| 2nd UP Forecast | 1.23 |
| 1st UP Forecast | 1.15 |
| 1st DOWN Forecast | 0.89 |
| 2nd DOWN Forecast | 0.81 |
| 3rd DOWN Forecast | 0.72 |
| 4th DOWN Forecast | 0.58 |
ENLV Forecast2025
| 4th UP Forecast | 3.47 |
| 3rd UP Forecast | 2.68 |
| 2nd UP Forecast | 2.2 |
| 1st UP Forecast | 1.71 |
| 1st DOWN Forecast | 0.33 |
| 2nd DOWN Forecast | -0.16 |
| 3rd DOWN Forecast | -0.64 |
| 4th DOWN Forecast | -1.43 |
Enlivex Therapeutics Ltd ( NASDAQ USA Symbol : ENLV )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ENLV Business Profile
Enlivex Therapeutics Ltd. operates as a clinical stage immunotherapy company. It is developing Allocetra, an off-the-shelf cell therapy designed to reprogram macrophages into homeostatic state. Resetting non-homeostatic macrophages into homeostatic state is critical for immune system rebalancing and resolution of life-threatening conditions. Diseases, such as solid cancers, sepsis, COVID-19, and others reprogram macrophages out of homeostatic state. Its Allocetra has the potential to provide a novel immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents. The company has a research collaboration with Yale Cancer Center for the assessment of Allocetra to enhance the activity of checkpoint inhibitors in solid tumors. Enlivex Therapeutics Ltd. was incorporated in 2005 and is headquartered in Nes Ziona, Israel. Address: 14 Einstein Street, Ness Ziona, Israel, 7403618
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service